Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-09-06 Purchase |
2023-09-07 4:16 pm |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
9,490 | $7.9 | $74,971 | 15,461 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-03 8:09 pm |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
1,894 | $12.45 | $23,579 | 16,081 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-01 Exercise |
2025-03-04 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
3,475 | $0 | 94,983 (Direct) |
View |
| 2025-03-01 Tax Withholding |
2025-03-04 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
727 | $1.99 | 94,983 (Direct) |
View |
| 2025-02-01 Tax Withholding |
2025-02-04 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
5,816 | $2.48 | 530,410 (Direct) |
View |
| 2025-02-01 Exercise |
2025-02-04 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
14,750 | $0 | 530,410 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-04 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
396,300 | $0 | 530,410 (Direct) |
View |
| 2024-12-31 Tax Withholding |
2025-01-03 6:25 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
38,221 | $2.48 | 236,476 (Direct) |
View |
| 2024-12-31 Exercise |
2025-01-03 6:25 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
94,450 | $0 | 236,476 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-03 6:25 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
40,000 | $0 | 236,476 (Direct) |
View |
| 2024-09-01 Exercise |
2024-09-04 7:52 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
1,000 | $0 | 24,697 (Direct) |
View |
| 2024-09-01 Tax Withholding |
2024-09-04 7:52 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
286 | $1.18 | 24,697 (Direct) |
View |
| 2024-03-01 Exercise |
2024-03-05 5:02 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
4,975 | $0 | 29,833 (Direct) |
View |
| 2024-03-01 Tax Withholding |
2024-03-05 5:02 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
1,417 | $1.24 | 29,833 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 7:27 pm |
N/A 2034-01-31 |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
413,000 | $0 | 413,000 (Direct) |
View |
| 2024-01-01 Tax Withholding |
2024-01-03 4:47 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
2,536 | $1.05 | 42,925 (Direct) |
View |
| 2024-01-01 Exercise |
2024-01-03 4:47 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
7,500 | $0 | 42,925 (Direct) |
View |
| 2023-09-01 Exercise |
2023-09-05 5:08 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
1,000 | $0 | 6,971 (Direct) |
View |
| 2023-09-01 Tax Withholding |
2023-09-05 5:08 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
285 | $7.9 | 6,971 (Direct) |
View |
| 2023-03-01 Exercise |
2023-03-03 8:09 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
6,450 | $0 | 16,081 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 4:55 pm |
N/A 2033-01-31 |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
135,000 | $0 | 135,000 (Direct) |
View |
Ownership |
2023-01-06 4:31 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Balthaser Kevin Chief Financial Officer |
0 | $0 | 82,175 (Direct) |
View |